Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00211536 · ClinicalTrials.gov registry record · Phase 3
Study Comparing Effectiveness of Intraperitoneal Insulin Administration to Subcutaneous Insulin Administration
A Phase 3 study, sponsored by Medtronic MiniMed.
- Completed
- Registry status
- Phase 3
- Development phase
- 107
- Enrollment target
NCT00211536: Completed Phase 3 study, sponsored by Medtronic MiniMed.
NCT00211536 is a Phase 3 study that has completed, run by Medtronic MiniMed. The registered enrollment target is 107 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00211536, a Phase 3 study, has completed, sponsored by Medtronic MiniMed.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 107 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effectiveness of insulin delivered in the peritoneum (abdomen)by an implantable pump in Type 1 diabetics.
Interventions
- DRUG Medtronic MiniMed Implantable Pump Human Recombinant Insulin
- DEVICE Medtronic MiniMed Implantable Pump System
- DRUG Aventis HOE21PH U400
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 107 participants |
| Start Date | 2002-06 |
| Est. Completion | 2008-09 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00211536
The ClinicalTrials.gov registry entry for NCT00211536 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 107 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic MiniMed, which has 29 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Medtronic MiniMed Implantable Pump Human Recombinant Insulin is the first listed.
NCT00211536 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00211536 about?
NCT00211536 is a clinical study titled "Study Comparing Effectiveness of Intraperitoneal Insulin Administration to Subcutaneous Insulin Administration". The purpose of this study is to evaluate the effectiveness of insulin delivered in the peritoneum (abdomen)by an implantable pump in Type 1 diabetics.
What is the current status of trial NCT00211536?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 107 participants. The study started on 2002-06. Estimated completion is 2008-09.
What interventions are being tested in trial NCT00211536?
The interventions under investigation include: Medtronic MiniMed Implantable Pump Human Recombinant Insulin (DRUG), Medtronic MiniMed Implantable Pump System (DEVICE), Aventis HOE21PH U400 (DRUG).
Who is sponsoring clinical trial NCT00211536?
This trial is sponsored by Medtronic MiniMed, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.